182 related articles for article (PubMed ID: 16167039)
1. False-positive findings with positron emission tomography in the staging of non-small-cell lung cancer.
Schneider BJ; Avram AM; Shulkin BL; Kalemkerian GP
Clin Adv Hematol Oncol; 2005 Jul; 3(7):571-3. PubMed ID: 16167039
[No Abstract] [Full Text] [Related]
2. Positron emission tomography staging of pleural deposits following Monaldi's procedure: an accurate reflection or a false staging?
Al-Sarraf N; Doddakula K; Wedde T; Young V
Interact Cardiovasc Thorac Surg; 2007 Apr; 6(2):260-1. PubMed ID: 17669837
[TBL] [Abstract][Full Text] [Related]
3. PET/CT in non-small cell lung cancer staging-promises and problems.
Devaraj A; Cook GJ; Hansell DM
Clin Radiol; 2007 Feb; 62(2):97-108. PubMed ID: 17207691
[TBL] [Abstract][Full Text] [Related]
4. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.
Lee BE; von Haag D; Lown T; Lau D; Calhoun R; Follette D
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):746-52. PubMed ID: 17320577
[TBL] [Abstract][Full Text] [Related]
5. The use of positron emission tomography (PET) in the staging/evaluation, treatment, and follow-up of patients with lung cancer: a critical review.
Mac Manus M; Hicks RJ
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1298-306. PubMed ID: 19028270
[No Abstract] [Full Text] [Related]
6. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less.
Khandani AH; Detterbeck FC
J Thorac Cardiovasc Surg; 2006 Jul; 132(1):214-5; author reply 215. PubMed ID: 16798357
[No Abstract] [Full Text] [Related]
7. Positron emission tomography imaging in nonsmall-cell lung cancer.
Erasmus JJ; Macapinlac HA; Swisher SG
Cancer; 2007 Nov; 110(10):2155-68. PubMed ID: 17896784
[TBL] [Abstract][Full Text] [Related]
8. Invasive aspergillosis mimicking stage IIIA non-small-cell lung cancer on FDG positron emission tomography.
Wilkinson MD; Fulham MJ; McCaughan BC; Constable CJ
Clin Nucl Med; 2003 Mar; 28(3):234-5. PubMed ID: 12592137
[No Abstract] [Full Text] [Related]
9. Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.
Shim SS; Lee KS; Kim BT; Chung MJ; Lee EJ; Han J; Choi JY; Kwon OJ; Shim YM; Kim S
Radiology; 2005 Sep; 236(3):1011-9. PubMed ID: 16014441
[TBL] [Abstract][Full Text] [Related]
10. [Current status of 18F-FDG PET in predicting outcome of cancer therapy].
Gong HY; Yu JM
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):577-80. PubMed ID: 16429617
[No Abstract] [Full Text] [Related]
11. Counterpoint: Despite staging inaccuracies, patients with non-small cell lung cancer are best served by having integrated positron emission tomography/computed tomography before therapy.
Cerfolio RJ
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):20-2. PubMed ID: 19154894
[No Abstract] [Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
13. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
[TBL] [Abstract][Full Text] [Related]
14. Oligometastatic non-small cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era.
De Pas TM; de Braud F; Catalano G; Putzu C; Veronesi G; Leo F; Solli PG; Brambilla D; Paganelli G; Spaggiari L
Ann Thorac Surg; 2007 Jan; 83(1):231-4. PubMed ID: 17184669
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
Vansteenkiste JF
Lung Cancer; 2005 Feb; 47(2):151-3. PubMed ID: 15639713
[No Abstract] [Full Text] [Related]
16. New horizons in staging for non-small-cell lung cancer.
Lardinois D
J Clin Oncol; 2006 Apr; 24(12):1785-7. PubMed ID: 16567767
[No Abstract] [Full Text] [Related]
17. Staging of non-small-cell lung cancer with positron-emission tomography.
Donckier JE; Roelants V; Pochet JM
N Engl J Med; 2000 Nov; 343(21):1572; author reply 1572-3. PubMed ID: 11184751
[No Abstract] [Full Text] [Related]
18. Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less.
Port JL; Andrade RS; Levin MA; Korst RJ; Lee PC; Becker DE; Altorki NK
J Thorac Cardiovasc Surg; 2005 Dec; 130(6):1611-5. PubMed ID: 16308006
[TBL] [Abstract][Full Text] [Related]
19. [Can positron-emission tomography modify the management of non-small-cell lung cancer?].
Ninane V
Rev Pneumol Clin; 2006 Feb; 62 Spec no 1():1S5-7. PubMed ID: 16719146
[No Abstract] [Full Text] [Related]
20. [The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer].
Melek H; Günlüoğlu MZ; Demir A; Akin H; Medetoğlu B; Kara HV; Olçmen A; Dinçer SI
Tuberk Toraks; 2008; 56(1):56-63. PubMed ID: 18330756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
